Abola - Theranos Walked Away From Investments for Unrelated Reasons

Elizabeth and sonny didn't tell scholtz that thernoss abola application was stalled because it had failed to answer the agency's questions. By the time of their talk at stanford, her interest in abola had waned as outbreak came under roll. She left him with the misleading impression that it was the fda being slow. A person with knowledge of the matter told me elizabeth who'd approached the c d c director tom freedon not the other way around. And freedon had found her claims about thernos test incomplete and plausible or inconsistent.